Status:
RECRUITING
Fluid Guided Heart Failure Treatment at the Cleveland Clinic
Lead Sponsor:
Bodyport Inc.
Conditions:
Heart Failure
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
FIGHT-HF is an exploratory non-randomized open-label study evaluating a heart failure management intervention. The goal of this pilot is to assess the performance of a fluid-guided heart failure mana...
Detailed Description
This study will assess the clinical integration of the Cardiac Scale and a composite biomarker algorithm, the Congestion Index and Alert, into existing health system workflows for HF management. The d...
Eligibility Criteria
Inclusion
- Hospitalized for acute decompensated heart failure
- Age 21 years or older
- Able to speak and read English
Exclusion
- New York Heart Association functional class IV symptoms
- Received or are scheduled to receive a heart transplant or ventricular assist - device in the next 12 months
- Have a glomerular filtration rate of less than 25 mL/min while nonresponsive to diuretic therapy or on chronic renal dialysis
- Have a history of regularly scheduled intravenous HF therapy (e.g., inotropes or diuretics)
- Have a life expectancy of less than 12 months
- Are pregnant or plan to become pregnant during the next 12 months
- Weigh greater than 375 lbs
- Unable to stand on two bare feet without assistance
Key Trial Info
Start Date :
October 8 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT07205120
Start Date
October 8 2025
End Date
March 1 2026
Last Update
November 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Cleveland Clinic
Cleveland, Ohio, United States, 44195